DK173565B1 - Præparater til anvendelse ved inhibering af caries samt phosphopeptider, en fremgangsmåde til fremstilling deraf og præpara - Google Patents

Præparater til anvendelse ved inhibering af caries samt phosphopeptider, en fremgangsmåde til fremstilling deraf og præpara Download PDF

Info

Publication number: DK173565B1
Authority: DK; Denmark
Prior art keywords: glu; pse; ile; val; asn
Prior art date: 1986-06-12

Application number

DK198800703A

Other languages

Danish (da)

English (en)

Other versions

DK70388D0 (da

DK70388A (da

Inventor

Eric Charles Reynolds

Original Assignee

Univ Melbourne

Victorian Dairy Ind

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-06-12

Filing date

1988-02-11

Publication date

2001-03-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3771654&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK173565(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1988-02-11 Application filed by Univ Melbourne, Victorian Dairy Ind filed Critical Univ Melbourne

1988-02-11 Publication of DK70388D0 publication Critical patent/DK70388D0/da

1988-04-11 Publication of DK70388A publication Critical patent/DK70388A/da

2001-03-19 Application granted granted Critical

2001-03-19 Publication of DK173565B1 publication Critical patent/DK173565B1/da

Links

108010001441 Phosphopeptides Proteins 0.000 title claims abstract description 64
238000002360 preparation method Methods 0.000 title claims description 24
238000000034 method Methods 0.000 title claims description 19
208000002925 dental caries Diseases 0.000 title claims description 14
230000002401 inhibitory effect Effects 0.000 title description 5
239000000203 mixture Substances 0.000 claims abstract description 67
150000003839 salts Chemical class 0.000 claims abstract description 24
108090000765 processed proteins & peptides Proteins 0.000 claims description 46
239000000243 solution Substances 0.000 claims description 27
239000001506 calcium phosphate Substances 0.000 claims description 26
229910000389 calcium phosphate Inorganic materials 0.000 claims description 26
235000011010 calcium phosphates Nutrition 0.000 claims description 26
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 26
102000011632 Caseins Human genes 0.000 claims description 23
108010076119 Caseins Proteins 0.000 claims description 23
229910052588 hydroxylapatite Inorganic materials 0.000 claims description 19
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 18
230000015556 catabolic process Effects 0.000 claims description 17
238000006731 degradation reaction Methods 0.000 claims description 17
239000005018 casein Substances 0.000 claims description 14
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 11
235000021240 caseins Nutrition 0.000 claims description 11
239000000463 material Substances 0.000 claims description 11
238000011049 filling Methods 0.000 claims description 8
235000009508 confectionery Nutrition 0.000 claims description 7
229940034610 toothpaste Drugs 0.000 claims description 7
239000000606 toothpaste Substances 0.000 claims description 7
239000003085 diluting agent Substances 0.000 claims description 6
230000000699 topical effect Effects 0.000 claims description 5
235000021247 β-casein Nutrition 0.000 claims description 5
239000002253 acid Substances 0.000 claims description 4
230000000694 effects Effects 0.000 claims description 4
-1 as-ca-signin Proteins 0.000 claims description 3
235000013305 food Nutrition 0.000 claims description 3
239000002324 mouth wash Substances 0.000 claims description 3
230000005764 inhibitory process Effects 0.000 claims description 2
229940051866 mouthwash Drugs 0.000 claims description 2
SWLOHUMCUDRTCL-ZLUOBGJFSA-N Asn-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N SWLOHUMCUDRTCL-ZLUOBGJFSA-N 0.000 claims 1
SBMNPABNWKXNBJ-BQBZGAKWSA-N Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CO SBMNPABNWKXNBJ-BQBZGAKWSA-N 0.000 claims 1
BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 abstract description 11
229950006137 dexfosfoserine Drugs 0.000 abstract description 9
BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 abstract description 8
229940024606 amino acid Drugs 0.000 abstract description 6
150000001413 amino acids Chemical class 0.000 abstract description 5
229940009098 aspartate Drugs 0.000 abstract description 5
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract description 4
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract description 4
229930195712 glutamate Natural products 0.000 abstract description 3
FDIKHVQUPVCJFA-UHFFFAOYSA-N phosphohistidine Chemical compound OP(=O)(O)NC(C(=O)O)CC1=CN=CN1 FDIKHVQUPVCJFA-UHFFFAOYSA-N 0.000 abstract description 2
DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 abstract description 2
USRGIUJOYOXOQJ-GBXIJSLDSA-N phosphothreonine Chemical compound OP(=O)(O)O[C@H](C)[C@H](N)C(O)=O USRGIUJOYOXOQJ-GBXIJSLDSA-N 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 description 25
239000011575 calcium Substances 0.000 description 21
235000002639 sodium chloride Nutrition 0.000 description 21
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 19
229910052791 calcium Inorganic materials 0.000 description 19
238000012360 testing method Methods 0.000 description 16
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 15
210000003298 dental enamel Anatomy 0.000 description 14
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
229910019142 PO4 Inorganic materials 0.000 description 11
235000021317 phosphate Nutrition 0.000 description 10
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
238000004090 dissolution Methods 0.000 description 9
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 9
239000010452 phosphate Substances 0.000 description 9
239000012588 trypsin Substances 0.000 description 9
108090000631 Trypsin Proteins 0.000 description 8
102000004142 Trypsin Human genes 0.000 description 8
239000000872 buffer Substances 0.000 description 8
PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 8
239000002244 precipitate Substances 0.000 description 7
239000011780 sodium chloride Substances 0.000 description 7
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 6
229910052500 inorganic mineral Inorganic materials 0.000 description 6
235000010755 mineral Nutrition 0.000 description 6
239000011707 mineral Substances 0.000 description 6
229940080237 sodium caseinate Drugs 0.000 description 6
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 5
235000001014 amino acid Nutrition 0.000 description 5
230000002328 demineralizing effect Effects 0.000 description 5
239000000126 substance Substances 0.000 description 5
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
239000007983 Tris buffer Substances 0.000 description 4
230000000170 anti-cariogenic effect Effects 0.000 description 4
XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
230000003902 lesion Effects 0.000 description 4
229910021645 metal ion Inorganic materials 0.000 description 4
239000011775 sodium fluoride Substances 0.000 description 4
235000013024 sodium fluoride Nutrition 0.000 description 4
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
OIXLLKLZKCBCPS-RZVRUWJTSA-N (2s)-2-azanyl-5-[bis(azanyl)methylideneamino]pentanoic acid Chemical compound OC(=O)[C@@H](N)CCCNC(N)=N.OC(=O)[C@@H](N)CCCNC(N)=N OIXLLKLZKCBCPS-RZVRUWJTSA-N 0.000 description 3
UJKDYMOBUGTJLZ-UHFFFAOYSA-N 2-azanylpentanedioic acid Chemical compound OC(=O)C(N)CCC(O)=O.OC(=O)C(N)CCC(O)=O UJKDYMOBUGTJLZ-UHFFFAOYSA-N 0.000 description 3
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 3
208000020084 Bone disease Diseases 0.000 description 3
KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
239000004472 Lysine Substances 0.000 description 3
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
229930006000 Sucrose Natural products 0.000 description 3
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
229960001230 asparagine Drugs 0.000 description 3
235000009582 asparagine Nutrition 0.000 description 3
235000012970 cakes Nutrition 0.000 description 3
229940071162 caseinate Drugs 0.000 description 3
235000013339 cereals Nutrition 0.000 description 3
239000013522 chelant Substances 0.000 description 3
238000005115 demineralization Methods 0.000 description 3
239000003599 detergent Substances 0.000 description 3
238000000605 extraction Methods 0.000 description 3
235000013312 flour Nutrition 0.000 description 3
238000005194 fractionation Methods 0.000 description 3
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
229910052742 iron Inorganic materials 0.000 description 3
239000007788 liquid Substances 0.000 description 3
238000002156 mixing Methods 0.000 description 3
238000012986 modification Methods 0.000 description 3
230000004048 modification Effects 0.000 description 3
239000000843 powder Substances 0.000 description 3
238000001556 precipitation Methods 0.000 description 3
230000000395 remineralizing effect Effects 0.000 description 3
239000005720 sucrose Substances 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
238000010998 test method Methods 0.000 description 3
239000010936 titanium Substances 0.000 description 3
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
238000002965 ELISA Methods 0.000 description 2
239000004471 Glycine Substances 0.000 description 2
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
MQUQNUAYKLCRME-INIZCTEOSA-N N-tosyl-L-phenylalanyl chloromethyl ketone Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N[C@H](C(=O)CCl)CC1=CC=CC=C1 MQUQNUAYKLCRME-INIZCTEOSA-N 0.000 description 2
208000001132 Osteoporosis Diseases 0.000 description 2
102000007982 Phosphoproteins Human genes 0.000 description 2
108010089430 Phosphoproteins Proteins 0.000 description 2
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
239000004473 Threonine Substances 0.000 description 2
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
235000004279 alanine Nutrition 0.000 description 2
229910052782 aluminium Inorganic materials 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
230000000844 anti-bacterial effect Effects 0.000 description 2
TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
235000013361 beverage Nutrition 0.000 description 2
235000008429 bread Nutrition 0.000 description 2
239000002775 capsule Substances 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
229910052802 copper Inorganic materials 0.000 description 2
239000013078 crystal Substances 0.000 description 2
239000008367 deionised water Substances 0.000 description 2
229910021641 deionized water Inorganic materials 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
235000015203 fruit juice Nutrition 0.000 description 2
239000000499 gel Substances 0.000 description 2
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
229960000310 isoleucine Drugs 0.000 description 2
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
229910052746 lanthanum Inorganic materials 0.000 description 2
230000014759 maintenance of location Effects 0.000 description 2
229930182817 methionine Natural products 0.000 description 2
239000006072 paste Substances 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
238000002601 radiography Methods 0.000 description 2
CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
229910052709 silver Inorganic materials 0.000 description 2
235000019333 sodium laurylsulphate Nutrition 0.000 description 2
NTJHYIRSENEXDR-UHFFFAOYSA-M sodium;fluoro-dioxido-oxo-$l^{5}-phosphane;hydron Chemical compound [Na+].OP([O-])(F)=O NTJHYIRSENEXDR-UHFFFAOYSA-M 0.000 description 2
239000007858 starting material Substances 0.000 description 2
229910052718 tin Inorganic materials 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
239000004474 valine Substances 0.000 description 2
IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
229910000497 Amalgam Inorganic materials 0.000 description 1
YFSLJHLQOALGSY-ZPFDUUQYSA-N Asp-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N YFSLJHLQOALGSY-ZPFDUUQYSA-N 0.000 description 1
235000007319 Avena orientalis Nutrition 0.000 description 1
241000209763 Avena sativa Species 0.000 description 1
235000007558 Avena sp Nutrition 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
102100027992 Casein kinase II subunit beta Human genes 0.000 description 1
101710158100 Casein kinase II subunit beta Proteins 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
108090000317 Chymotrypsin Proteins 0.000 description 1
208000002064 Dental Plaque Diseases 0.000 description 1
208000018035 Dental disease Diseases 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
244000068988 Glycine max Species 0.000 description 1
235000010469 Glycine max Nutrition 0.000 description 1
240000005979 Hordeum vulgare Species 0.000 description 1
235000007340 Hordeum vulgare Nutrition 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
241000899717 Itaya Species 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
208000034693 Laceration Diseases 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
QUAAUWNLWMLERT-IHRRRGAJSA-N Leu-Arg-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(O)=O QUAAUWNLWMLERT-IHRRRGAJSA-N 0.000 description 1
VKOAHIRLIUESLU-ULQDDVLXSA-N Leu-Arg-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O VKOAHIRLIUESLU-ULQDDVLXSA-N 0.000 description 1
206010025476 Malabsorption Diseases 0.000 description 1
208000004155 Malabsorption Syndromes Diseases 0.000 description 1
101100496858 Mus musculus Colec12 gene Proteins 0.000 description 1
101100005306 Mus musculus Ctso gene Proteins 0.000 description 1
DAOANAATJZWTSJ-UHFFFAOYSA-N N-Decanoylmorpholine Chemical compound CCCCCCCCCC(=O)N1CCOCC1 DAOANAATJZWTSJ-UHFFFAOYSA-N 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
108090000526 Papain Proteins 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
QKFJKGMPGYROCL-UHFFFAOYSA-N Phenyl isothiocyanate Natural products S=C=NC1=CC=CC=C1 QKFJKGMPGYROCL-UHFFFAOYSA-N 0.000 description 1
108010059712 Pronase Proteins 0.000 description 1
239000004365 Protease Substances 0.000 description 1
241000209056 Secale Species 0.000 description 1
235000007238 Secale cereale Nutrition 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
208000014151 Stomatognathic disease Diseases 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
108090001109 Thermolysin Proteins 0.000 description 1
241000209140 Triticum Species 0.000 description 1
235000021307 Triticum Nutrition 0.000 description 1
101710119636 Trypsin-5 Proteins 0.000 description 1
CPGKMLVTFNUAHL-UHFFFAOYSA-N [Ca].[Ca] Chemical compound [Ca].[Ca] CPGKMLVTFNUAHL-UHFFFAOYSA-N 0.000 description 1
239000008272 agar Substances 0.000 description 1
208000007502 anemia Diseases 0.000 description 1
238000005571 anion exchange chromatography Methods 0.000 description 1
230000003110 anti-inflammatory effect Effects 0.000 description 1
230000002788 anti-peptide Effects 0.000 description 1
230000002882 anti-plaque Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-L aspartate group Chemical group N[C@@H](CC(=O)[O-])C(=O)[O-] CKLJMWTZIZZHCS-REOHCLBHSA-L 0.000 description 1
WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
229910001626 barium chloride Inorganic materials 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
235000021152 breakfast Nutrition 0.000 description 1
235000015496 breakfast cereal Nutrition 0.000 description 1
230000003139 buffering effect Effects 0.000 description 1
FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
229910001424 calcium ion Inorganic materials 0.000 description 1
230000025938 carbohydrate utilization Effects 0.000 description 1
235000014171 carbonated beverage Nutrition 0.000 description 1
230000001013 cariogenic effect Effects 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
229940112822 chewing gum Drugs 0.000 description 1
235000015218 chewing gum Nutrition 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
229960002376 chymotrypsin Drugs 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
235000020247 cow milk Nutrition 0.000 description 1
235000013365 dairy product Nutrition 0.000 description 1
238000001212 derivatisation Methods 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
235000019700 dicalcium phosphate Nutrition 0.000 description 1
229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
239000000975 dye Substances 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000000945 filler Substances 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
235000019634 flavors Nutrition 0.000 description 1
DWYMPOCYEZONEA-UHFFFAOYSA-L fluoridophosphate Chemical compound [O-]P([O-])(F)=O DWYMPOCYEZONEA-UHFFFAOYSA-L 0.000 description 1
235000012041 food component Nutrition 0.000 description 1
239000005428 food component Substances 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
208000007565 gingivitis Diseases 0.000 description 1
239000008103 glucose Substances 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
235000015243 ice cream Nutrition 0.000 description 1
238000005286 illumination Methods 0.000 description 1
239000012535 impurity Substances 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
238000011835 investigation Methods 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
229910000155 iron(II) phosphate Inorganic materials 0.000 description 1
SDEKDNPYZOERBP-UHFFFAOYSA-H iron(ii) phosphate Chemical compound [Fe+2].[Fe+2].[Fe+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O SDEKDNPYZOERBP-UHFFFAOYSA-H 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
230000005923 long-lasting effect Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
235000013372 meat Nutrition 0.000 description 1
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
235000014571 nuts Nutrition 0.000 description 1
208000008798 osteoma Diseases 0.000 description 1
208000005368 osteomalacia Diseases 0.000 description 1
229940055729 papain Drugs 0.000 description 1
235000019834 papain Nutrition 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
208000028169 periodontal disease Diseases 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
229940117953 phenylisothiocyanate Drugs 0.000 description 1
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
229920000058 polyacrylate Polymers 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
239000002243 precursor Substances 0.000 description 1
239000000047 product Substances 0.000 description 1
235000018102 proteins Nutrition 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
238000004007 reversed phase HPLC Methods 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
229940081974 saccharin Drugs 0.000 description 1
235000019204 saccharin Nutrition 0.000 description 1
239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
239000012266 salt solution Substances 0.000 description 1
230000007017 scission Effects 0.000 description 1
239000000661 sodium alginate Substances 0.000 description 1
235000010413 sodium alginate Nutrition 0.000 description 1
229940005550 sodium alginate Drugs 0.000 description 1
WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
235000010234 sodium benzoate Nutrition 0.000 description 1
239000004299 sodium benzoate Substances 0.000 description 1
241000894007 species Species 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
239000007921 spray Substances 0.000 description 1
235000011149 sulphuric acid Nutrition 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
230000009974 thixotropic effect Effects 0.000 description 1
239000004408 titanium dioxide Substances 0.000 description 1
229940042129 topical gel Drugs 0.000 description 1
238000000108 ultra-filtration Methods 0.000 description 1
235000013311 vegetables Nutrition 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1
235000021249 α-casein Nutrition 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Bioinformatics & Cheminformatics (AREA)
Birds (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oral & Maxillofacial Surgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Cosmetics (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
General Preparation And Processing Of Foods (AREA)
Non-Alcoholic Beverages (AREA)
Cereal-Derived Products (AREA)
Bakery Products And Manufacturing Methods Therefor (AREA)

DK198800703A 1986-06-12 1988-02-11 Præparater til anvendelse ved inhibering af caries samt phosphopeptider, en fremgangsmåde til fremstilling deraf og præpara DK173565B1 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
AUPH638586		1986-06-12
AUPH638586		1986-06-12
PCT/AU1987/000172 WO1987007615A1 (fr)	1986-06-12	1987-06-12	Phosphopeptides
AU8700172		1987-06-12

Publications (3)

Publication Number	Publication Date
DK70388D0 DK70388D0 (da)	1988-02-11
DK70388A DK70388A (da)	1988-04-11
DK173565B1 true DK173565B1 (da)	2001-03-19

Family

ID=3771654

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK198800703A DK173565B1 (da)	1986-06-12	1988-02-11	Præparater til anvendelse ved inhibering af caries samt phosphopeptider, en fremgangsmåde til fremstilling deraf og præpara

Country Status (12)

Country	Link
EP (1)	EP0268663B1 (fr)
JP (1)	JPH0776235B2 (fr)
AT (1)	ATE132161T1 (fr)
BR (1)	BR8707352A (fr)
CA (1)	CA1315480C (fr)
DE (1)	DE3751652T2 (fr)
DK (1)	DK173565B1 (fr)
FI (1)	FI92709C (fr)
HU (1)	HUT47309A (fr)
NO (1)	NO178665C (fr)
NZ (1)	NZ220673A (fr)
WO (1)	WO1987007615A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4606674A (en) *	1984-04-23	1986-08-19	Capron Mark E	Structural wheel element
GB8811830D0 (en) *	1988-05-19	1988-06-22	Unilever Plc	Oral compositions
GB8811829D0 (en) *	1988-05-19	1988-06-22	Unilever Plc	Oral compositions
DK0391629T3 (da) *	1989-04-07	1997-12-15	Univ South Alabama	Inhibering af mineralaflejring ved hjælp af phosphorylerede og beslægtede polyanioniske peptider
US5290685A (en) *	1990-02-22	1994-03-01	Meiji Milk Products Company Limited	Method for separation and concentration of phosphopeptides
DE4007431A1 (de) *	1990-03-09	1991-09-12	Henkel Kgaa	Den zahnschmelz schuetzende mund- und zahnpflegemittel
EP0523776A3 (en) *	1991-07-17	1993-05-26	Unilever N.V.	Oral compositions containing a phosphopeptide
GB9117315D0 (en) *	1991-08-09	1991-09-25	Unilever Plc	Method of controlling dental tartar and compositions for use therein
ES2144458T3 (es) *	1992-06-29	2000-06-16	Univ Melbourne	Tratamiento para dientes sensibles.
CA2181109A1 (fr)	1995-07-18	1997-01-19	Nobuko Imajo	Polypeptide et methode pour mesurer les constituants provenant d'un organisme vivant
US5837674A (en)	1996-07-03	1998-11-17	Big Bear Bio, Inc.	Phosphopeptides and methods of treating bone diseases
AUPO566297A0 (en)	1997-03-13	1997-04-10	University Of Melbourne, The	Calcium phosphopeptide complexes
AUPP051497A0 (en) *	1997-11-24	1997-12-18	University Of Melbourne, The	Antimicrobial peptides
AUPP494798A0 (en)	1998-07-29	1998-08-20	Pacific Biolink Pty Limited	Protective protein formulation
CN1201720C (zh) *	1999-03-25	2005-05-18	卡德伯里亚当斯美国有限责任公司	口腔保健用的口香糖和糖果
US6846500B1 (en) *	1999-03-25	2005-01-25	Cadbury Adams Usa Llc	Oral care chewing gums and method of use
AUPR517701A0 (en)	2001-05-21	2001-06-14	University Of Melbourne, The	Dental restorative materials
AU2005306857A1 (en)	2004-11-16	2006-05-26	3M Innovative Properties Company	Dental compositions with calcium phosphorus releasing glass
ATE493108T1 (de)	2004-11-16	2011-01-15	3M Innovative Properties Co	Dentalfüllstoffe und zusammensetzungen mit phosphatsalzen
CA2587556A1 (fr)	2004-11-16	2006-05-26	3M Innovative Properties Company	Produits d'obturation dentaire comprenant un traitement de surface contenant du phosphore, compositions et methodes associees
DE602005023509D1 (de) *	2004-11-16	2010-10-21	3M Innovative Properties Co	Dentalfüllstoffe, verfahren, zusammensetzungen mit einem caseinat
EP1827366B1 (fr) *	2004-11-25	2017-03-15	The University of Melbourne	Complexes stabilises de phosphate de calcium
EP1888014B1 (fr)	2005-06-07	2012-11-14	The University of Melbourne	Mineralisation dentaire
MX2007016312A (es)	2005-06-24	2008-03-05	Univ Melbourne	Complejos ionicos.
WO2007049757A1 (fr)	2005-10-27	2007-05-03	Sunstar Inc.	Inhibiteur de la formation d’osteoclastes, composition administree par voie orale et agent prophylactique ou therapeutique visant les maladies osseuses comprenant un liposome contenant de la lactoferrine
US9668945B2 (en)	2006-02-09	2017-06-06	The University Of Melbourne	Fluoride composition and methods for dental mineralization
DK3024428T3 (da)	2013-07-23	2021-01-18	Univ Melbourne	Sammensætninger og fremgangsmåder til dental mineralisering
AU2014373625B2 (en)	2013-12-24	2018-07-19	The University Of Melbourne	Stabilized stannous compositions
US11717536B2 (en)	2017-03-14	2023-08-08	The University Of Melbourne	Treatment for periodontitis
NZ757004A (en)	2017-03-14	2023-05-26	Univ Melbourne	Complexes for treating sensitivity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU520417B2 (en) *	1977-09-07	1982-01-28	Sandoz Ltd	Pentapeptides and derivatives
FR2474829B1 (fr) *	1980-02-01	1983-09-09	Agronomique Inst Nat Rech	Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
FR2474828B1 (fr) *	1980-02-01	1983-09-09	Agronomique Inst Nat Rech	Procede de traitement d'une matiere premiere a base de caseine, contenant des phosphocaseinates de cations bivalents, produits obtenus et application
NZ199891A (en) *	1981-03-04	1985-07-31	Univ Melbourne	Caries-inhibiting compositions containing casein or x-s-casein or phosuitin
US4463092A (en) *	1982-09-27	1984-07-31	Eli Lilly And Company	Process for production antibiotic A53868
DE3320175A1 (de) *	1983-06-03	1984-12-06	Boehringer Mannheim Gmbh, 6800 Mannheim	Aminosaeure- bzw. peptidderivate, verfahren zu deren herstellung und verwendung als arzneimittel

1987
- 1987-06-11 CA CA000539452A patent/CA1315480C/fr not_active Expired - Lifetime
- 1987-06-12 JP JP62503719A patent/JPH0776235B2/ja not_active Expired - Lifetime
- 1987-06-12 HU HU873314A patent/HUT47309A/hu unknown
- 1987-06-12 NZ NZ220673A patent/NZ220673A/xx unknown
- 1987-06-12 WO PCT/AU1987/000172 patent/WO1987007615A1/fr not_active Ceased
- 1987-06-12 DE DE3751652T patent/DE3751652T2/de not_active Expired - Lifetime
- 1987-06-12 BR BR8707352A patent/BR8707352A/pt unknown
- 1987-06-12 EP EP87904015A patent/EP0268663B1/fr not_active Expired - Lifetime
- 1987-06-12 AT AT87904015T patent/ATE132161T1/de not_active IP Right Cessation
1988
- 1988-02-10 NO NO880589A patent/NO178665C/no unknown
- 1988-02-11 FI FI880629A patent/FI92709C/fi not_active IP Right Cessation
- 1988-02-11 DK DK198800703A patent/DK173565B1/da not_active IP Right Cessation

Also Published As

Publication number	Publication date
FI880629A0 (fi)	1988-02-11
HUT47309A (en)	1989-02-28
EP0268663A4 (fr)	1990-04-10
FI92709B (fi)	1994-09-15
FI92709C (fi)	1994-12-27
AU7548387A (en)	1988-01-11
DK70388D0 (da)	1988-02-11
DE3751652T2 (de)	1996-07-25
DE3751652D1 (en)	1996-02-08
ATE132161T1 (de)	1996-01-15
NO880589D0 (no)	1988-02-10
JPH0776235B2 (ja)	1995-08-16
JPS63503459A (ja)	1988-12-15
NZ220673A (en)	1990-05-28
BR8707352A (pt)	1988-09-13
NO880589L (no)	1988-04-06
NO178665B (no)	1996-01-29
DK70388A (da)	1988-04-11
WO1987007615A1 (fr)	1987-12-17
FI880629L (fi)	1988-02-11
EP0268663A1 (fr)	1988-06-01
NO178665C (no)	1996-05-08
EP0268663B1 (fr)	1995-12-27
AU593365B2 (en)	1990-02-08
CA1315480C (fr)	1993-03-30

Publication	Publication Date	Title
DK173565B1 (da)	2001-03-19	Præparater til anvendelse ved inhibering af caries samt phosphopeptider, en fremgangsmåde til fremstilling deraf og præpara
US5015628A (en)	1991-05-14	Anticariogenic phosphopeptides
US7312193B2 (en)	2007-12-25	Calcium phosphopeptide complexes
AU2005309327B2 (en)	2010-11-25	Stabilized calcium phosphate complexes
KR100225820B1 (ko)	1999-10-15	치석 처리용 포스포펩티드
RU2697878C2 (ru)	2019-08-21	Композиции и способы для минерализации зубов
EP1901702A1 (fr)	2008-03-26	Complexes ioniques
EP1010430B1 (fr)	2007-06-06	Substances a action preventive et agents d'amelioration de la parodontose
JP2022524855A (ja)	2022-05-10	石灰化を促進するための組成物及び方法
EP3595630A1 (fr)	2020-01-22	Complexes pour le traitement de la sensibilité
CN102358746A (zh)	2012-02-22	表面活性钙磷酸盐
FI93171B (fi)	1994-11-30	Menetelmä terapeuttisesti aktiivisten fosfopeptidien valmistamiseksi
AU593365C (en)	1990-11-29	Phosphopeptides
AU746314B2 (en)	2002-04-18	Calcium phosphopeptide complexes

Legal Events

Date	Code	Title	Description
2001-03-19	B1	Patent granted (law 1993)
2007-07-02	PUP	Patent expired